Niraparib(Zejula)

Release date: 2026-01-05 14:04:26     Recommended: 9

It is indicated for the treatment of relapsed or refractory acute leukemia (with KMT2A translocation) or relapsed or refractory acute myeloid leukemia (with NPM1 mutation) in adult patients and pediat